ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000017650
Date of registration:	22/05/2015
Prospective Registration:	No
Primary sponsor:	School of Medicine, Keio University
Public title:	Clinical usefulness of fecal calprotectin for ulcerative colitis
Scientific title:	Clinical usefulness of fecal calprotectin for ulcerative colitis - Triple-C study
Date of first enrolment:	2015/01/01
Target sample size:	2000
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020452
Study type:	Observational
Study design:	Not selected Not selected
Phase:	Not applicable

Countries of recruitment
Japan

Contacts

Name:	Makoto Naganuma
Address:	35 Shinanomachi, Shinjuku-KU Tokyo 1608582 Japan
Telephone:	03-3353-1211
Email:	nagamakoto@z7.keio.ac.jp
Affiliation:	School of Medicine, Keio University Division of Gastroenterology and Hepatoligy

Name:	Takanori Kanai
Address:	35 Shinanomachi, Shinjuku-KU Tokyo Japan
Telephone:	81-3-3353-1211
Email:	takagast@z2.keio.jp
Affiliation:	School of Medicine, Keio University Division of Gastroenterology and Hepatoligy

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: Patients who received total colectomy Patients who received bowel resection within 6 months prior to entry of this study Patients who have recent GI bleeding, infectious colitis or colonic adenocarcinoma. Patients who received leukocyte or granulocyte- monocyte apheresis therapy. Patients who received non-steroid anti-inflammatory agent (NSAID).

Age minimum: 18years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

ulcerative colitis

Intervention(s)

Primary Outcome(s)

To evaluate relation between fecal calprotectin/fecal occult blood test and endoscopic severity To evaluate usefulness of fecal calprotectin/fecal occult blood test on long-term prognosis of UC

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

thermoscientific company

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date: 12/12/2014
Contact:

med-rinri-jimu@adst.keio.ac.jp

Keio Universisy, School of Medicine

03-333-1211

med-rinri-jimu@adst.keio.ac.jp

Results

Results available:	Yes
Date Posted:	08/09/2019
Date Completed:	31/03/2018
URL:	https://www.ncbi.nlm.nih.gov/pubmed/31394288

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.